4Filed Aug 25, 8:00 PM ET

Orthopediatrics (KIDS) 10% Owner Squadron Capital Sells Shares

$KIDS · ORTHOPEDIATRICS CORP

Research Summary

AI-generated summary of this SEC filing

Updated

Orthopediatrics (KIDS) 10% Owner Squadron Capital Sells Shares

What Happened Squadron Capital LLC, identified as a 10% owner of Orthopediatrics Corp (KIDS), sold a total of 38,300 shares in open-market/private transactions between August 24 and August 26, 2026, generating approximately $943,302 in proceeds. The filing reports three dispositions: 4,000 shares at a weighted average price of $25.75 (≈ $103,000), 16,300 shares at a weighted average price of $24.74 (≈ $403,262), and 18,000 shares at a weighted average price of $24.28 (≈ $437,040). These are outright sales (S), not purchases or option exercises.

Key Details

  • Transaction dates and reported weighted-average prices:
    • 2026-08-24: 4,000 shares @ $25.75 (weighted avg; per-footnote range $25.50–$25.82)
    • 2026-08-25: 16,300 shares @ $24.74 (weighted avg; per-footnote range $24.53–$24.88)
    • 2026-08-26: 18,000 shares @ $24.28 (weighted avg; per-footnote range $24.13–$24.36)
  • Total shares sold: 38,300; total proceeds: approximately $943,302.
  • Shares owned after the transactions: not specified in the provided excerpt of the filing.
  • Notable footnotes:
    • F1: Squadron states the sale was to provide additional capital for its other portfolio businesses.
    • F2–F5: The reported prices are weighted averages; the filing provides price ranges for the component trades and offers to supply breakdowns on request to the issuer, shareholders, or SEC staff.
    • F3: Securities are held directly by Squadron Capital LLC; Squadron Capital Holdings LLC is the controlling member.
  • Filing/timeliness: Form filed on Aug 26, 2026 reporting transactions through Aug 26; the filing excerpt does not indicate a late filing.

Context

  • Squadron Capital is a institutional 10% owner, not an individual executive. Institutional sales often reflect portfolio management or capital needs rather than insider views about the company’s prospects. Footnote F1 explicitly states the proceeds were intended to support other portfolio businesses.